About MEDREGEN, LLC
MedRegen LLC is a clinical stage pharmaceutical company developing novel therapeutics for the treatment of different types of organ and tissue injury. The company focuses on regenerative medicine through immunomodulation and stem cell mobilization.
Development of novel therapeutics for organ and tissue injuryImmunomodulatory and regenerative therapy researchClinical trials for drug candidates (e.g., MRG-001)Preclinical research and development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MEDREGEN, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.